Heart failure (HF) remains a leading cause of cardiovascular mortality and affects more than 64 million people globally. Early identification of patients at risk can support timely treatment and decision making by hospital and primary care clinicians. This preprint evaluates whether deep learning approaches can outperform classical machine learning on a multimodal clinical prediction task: predicting HF within a 48‑hour window prior to the first clinical evidence of disease using data from MIMIC‑IV.
The work compares a tree‑based method (XGBoost) with a Transformer‑based bidirectional cross‑attention model trained on combinations of structured data, laboratory values, radiology, medications, and clinical notes. The authors emphasize both predictive performance and interpretability, including development of an explainable dashboard to deliver quantitative 48‑hour risk estimates from a limited feature set.
Patients with and without HF were identified in MIMIC‑IV using ICD‑9 and ICD‑10 diagnosis codes. The diagnostic labels were supplemented and corroborated by clinical evidence drawn from laboratory results, radiology reports, and discharge notes to define the timing of the first clinical indication of HF.
The authors used multiple MIMIC resources: the primary MIMIC‑IV clinical database and the MIMIC note repository. They note that access to MIMIC‑IV is restricted to credentialed users who have completed required human subjects training and signed a data use agreement. Data availability links and dataset DOIs are provided in the preprint.
To model early detection, the team defined a 48‑hour prediction horizon prior to the first recorded clinical evidence of HF. Structured features were engineered from rolling‑window statistics and clinical thresholds applied to time‑series laboratory and medication data. The study evaluated models trained on single modalities and on multimodal combinations to determine the incremental value of each data source.
Two primary architectures were implemented and compared:
The Transformer model was intended to better capture the representational richness of clinical notes, while XGBoost leveraged tabular structured features derived from rolling windows and clinical thresholds.
An ablation study assessed the contribution of individual modalities to overall performance for each architecture. The authors report that multimodal models outperformed single‑modality variants in both XGBoost and Transformer settings. According to reported results, structured data provided the largest contribution to XGBoost performance (reported PR‑AUC 0.9163), while note‑level information was better captured by the Transformer (reported PR‑AUC 0.8220 for notes alone).
Model performance was assessed using standard classification metrics focused on recall‑precision behavior. Key reported metrics for multimodal models were:
These results indicate that, in this tabular‑dominated multimodal setting, the classical ML model achieved marginally higher performance than the Transformer while retaining interpretability via feature contributions. The authors highlight that multimodal integration improved performance compared with single modalities for both architectures.
To support clinical usability and transparency, the authors developed an explainable dashboard that computes a 48‑hour HF risk estimate from a small set of laboratory and medication features. The dashboard is intended to deliver quantitative risk scores and to provide explainability to aid clinician interpretation and diagnosis. Specific implementation details and the dashboard interface are described in the preprint; code and external links are referenced by the authors.
The authors state that Institutional Review Boards at MIT and Beth Israel Deaconess Medical Center waived ethical approval because the study is a secondary analysis of de‑identified, publicly accessible MIMIC‑IV data. The preprint explicitly notes that the work has not been peer reviewed and should not be used to guide clinical practice. All data used are available via PhysioNet subject to credentialing and a data use agreement; dataset DOIs and links are provided in the preprint.
Limitations mentioned or implied by the study include the retrospective design, reliance on ICD coding and extracted clinical evidence to define HF onset, and the common constraints of secondary analysis of a single critical‑care database. The preprint format means further peer review and external validation would be required before clinical deployment.
This preprint compares XGBoost and a Transformer‑based cross‑attention model for early HF prediction using multimodal MIMIC‑IV data and a 48‑hour prediction window. Multimodal approaches outperformed single‑modality models; the multimodal XGBoost model achieved the highest reported F1 and PR‑AUC (F1 0.8773, PR‑AUC 0.9402), while the Transformer performed slightly lower (F1 0.8635, PR‑AUC 0.9209). Structured tabular features drove XGBoost performance whereas clinical notes added more value to the Transformer. An explainable dashboard was developed to present 48‑hour risk estimates from minimal inputs. The authors provide data and code links, report IRB waivers for use of de‑identified data, and caution that the preprint is not peer reviewed and should not guide clinical care.